11/25/2024
5:03 AM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
11:12 AM | Oncternal Therapeutics, Inc. (Subject)
Oncternal Therapeutics (Subject)
Yazji Salim (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:49 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:30 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:17 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
11:15 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form EFFECT | |
04/26/2024
3:17 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form ARS | |
04/26/2024
3:13 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
3:15 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
7:38 PM | Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:00 PM | Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:42 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/15/2024
5:00 PM | Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
VINCENT RICHARD G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:00 PM | Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
Yazji Salim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:00 PM | Krishnan Rajesh (Reporting)
Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:00 PM | Leavitt Chase C. (Reporting)
Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:00 PM | BREITMEYER JAMES B (Reporting)
Oncternal Therapeutics, Inc. (Issuer)
Oncternal Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:05 PM | Oncternal Therapeutics, Inc. (Filer)
Oncternal Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
